Conagen develops cost-effective and sustainable Lactoferrin, a key protein ingredient for infant nutrition, dietary supplements and pharmaceuticals. The breakthrough comes at an opportune time when there is a driving market need in the use of microbes to produce some of the most marketable and desirable components of breast milk.